Japanese Researchers Take Spotlight In International Biomedical Program

Tokyo proposed the Human Frontier Program; now its scientists are among the first to take advantage of it STRASBOURG, FRANCE -- Biomedical researchers from around the world will have a second chance next month to participate in Japan's Human Frontier Science Program now that Tokyo has led the way in the first round of funding. The program was first proposed in 1986 by former Japanese Prime Minister Yosuhiro Nakasone at a summit conference of the seven leading democratic industrial nations -

Written byAlexander Dorozynski
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share


Tokyo proposed the Human Frontier Program; now its scientists are among the first to take advantage of it
STRASBOURG, FRANCE -- Biomedical researchers from around the world will have a second chance next month to participate in Japan's Human Frontier Science Program now that Tokyo has led the way in the first round of funding.

The program was first proposed in 1986 by former Japanese Prime Minister Yosuhiro Nakasone at a summit conference of the seven leading democratic industrial nations - the United States, Canada, United Kingdom, France, West Germany, Italy, and Japan. It was seen as a response to his country's reliance on the U.S. and other nations to train and fund its current generation of basic researchers in the life sciences, and its name conveys the grand hope to push back the frontiers of knowledge in the field.

But Nakasone's billion-dollar scheme was whittled down by his successors ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo